Grant-Funded Research
Research Papers are the results of OHE’s grant-funded research programmes intended to promote discussion and provide information prior to publication in a peer reviewed journal
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
Diagnostics not only facilitate health gain and cost savings, but also provide information to inform patients’ decisions on interventions and to clarify how their behaviour may…
The Tougher the Better: The Effect of an Increased Performance Threshold on the Performance of General Practitioners
4 January 2012
In April 2006, payment thresholds were raised for GPs who participate in Scotland’s Ouality and Outcomes Framework. GPs were required to meet new, higher thresholds on…
Assessing the Performance of the EQ-VAS in the NHS PROMs Programme
1 April 2012
The NHS Patient Reported Outcome Measures (PROMs) programme, introduced in April 2009, is a significant development in the routine collection and use of patient reported outcome…
Valuing Health at the End of Life: An Exploratory Preference Elicitation Study
1 December 2011
In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that…
The Effect of an Increase in the Rate of Payment on General Practitioner’s Intrinsic and Extrinsic Motivation
1 November 2011
This paper investigates how the increased rate of Quality and Outcomes Framework (QOF) payments implemented on 1 April 2005 affects Scottish general practitioners’ (GPs) intrinsic, extrinsic…
Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
1 August 2011
Recent reforms to the National Health Service (NHS) in England include important changes in the regulation of prices for new medicines. From January 2014, the existing…
Is the Aim of the Health Care System to Maximise QALYs? An Investigation of
1 May 2011
The appraisal of health care technologies by the UK’s National Institute for Health and Clinical Excellent (NICE) focuses on cost effectiveness, usually measured in terms of…
Incentives for R&D for New Antimicrobial Drugs
1 April 2011
Antimicrobial resistance (AMR) is becoming a major global public health threat and has begun to command attention from European and US policy makers. An initial focus…
Managing Poorly Performing Clinicians: The Value of Independent Help
1 March 2011
The UK’s National Clinical Assessment Agency (NCAS) is designed specifically to provide advice on performance issues, on request, to NHS organisations employing or contracting with doctors,…